Averin Insights: Before Disease Decides | Thierry Bernard & David Berry
What does the future of diagnostics look like - and can medicine move from reacting to disease to identifying biological signals ...
Chief Executive Officer, Qiagen
Search every verified Thierry Bernard interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Thierry Bernard, Chief Executive Officer of QIAGEN, recently participated in two public discussions, including an appearance on the "Averin Insights: Before Disease Decides" series with David Berry and a Fireside Chat chaired by Adelina Ivanova of Novartis Biomedical Research. In these conversations, Bernard discussed the role of diagnostics in healthcare, noting that diagnostic testing accounts for roughly 3 to 5 percent of hospital expenses while influencing at least 70 percent of clinical decisions. He also commented on the healthcare system's tendency to prioritize treatment over prevention, attributing this to conservatism and the time required to change standards of care. During the Fireside Chat, Bernard offered leadership advice, emphasizing the distinction between authority and credibility, and stated that titles are unnecessary for earning trust. He also addressed gender representation in management, recounting that he had advocated for favoring women candidates with equal competencies to address an imbalance, citing that while QIAGEN's overall workforce was 52 percent women at the time, management was only 29 percent women. His remarks on this topic were presented as a personal stance on correcting perceived disparities.
What does the future of diagnostics look like - and can medicine move from reacting to disease to identifying biological signals ...
Fireside Chat | Fireside Chat. Thierry Bernard (QIAGEN), chaired by Adelina Ivanova (Novartis Biomedical Research) | Excellentium2026 Global Biotech Revolution aims to inspire future leaders, build communities and develop young talent in biotech and healthcare. At GBR, we bridge the gap between the aspirations of young leaders and the talent education, management, and recruitment needs of the industry. Our mission is to cultivate a culture of talented, connected, and collaborative bio-leaders who are equipped with the skills and mindset to shape the future. Follow us on our other social medi…
Full name: Thierry L. Bernard Title: Chief Executive Officer Website: https://www.qiagen.com/us Ticker: $QGEN Biography: Thierry Bernard joined QIAGEN in February 2015 to lead the company’s growing presence in molecular diagnostics, the application of Sample to Insight solutions for molecular testing in human healthcare. He was named Chief Executive Officer in March 2020 after serving in this role on an interim basis and became a member of the Managing Board in 2021. Previously, Mr. Bernard held roles of increasing responsibility during 15 years with bioMérieux SA, most recently as Corp…
In this week’s episode, Qiagen CEO Thierry Bernard gives us a look inside the diagnostics leader both today and a few years ago when it was responded to the world’s dire need for diagnostics. Bernard takes us back to the early days of the pandemic, including his perspective on how different countries responded to the crisis. We’ll also hear his vision for the future of diagnostics including how Qiagen will make testing even simpler. At the start of the show, Host Tom Salemi and Chris Newmarker, executive editor of life sciences, talk with Senior Editor Danielle Kirsh about the recently rele…
What a genuine pleasure to sit with Thierry Bernard, CEO of Qiagen. As I told Thierry, Qiagen is a truly iconic brand for anyone who came up through molecular biology laboratories in the past 30 years. Their products were ubiquitous, and crucial, to the success of our research. In this conversation, Thierry talks about his global vision for precision medicine, and his mantra that we leave no patient behind. Episode 39 links: • TPM E39 for highlights and links from this episode ＞ (https://www.genialis.com/2024/10/08/l...) • Genialis™ krasID…
Thierry Bernard joined QIAGEN in February 2015 to lead the company’s growing presence in molecular diagnostics, the application of Sample to Insight solutions for molecular testing in human healthcare. He was named Chief Executive Officer in March 2020 after serving in this role on an interim basis and became a member of the Managing Board in 2021. Previously, Mr. Bernard held roles of increasing responsibility during 15 years with bioMérieux SA, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region, and held senior management…
Thierry Bernard's interview during the Excellerator 2023.
#Qiagen #COVID19 #coronavirus #yahoofinance This segment originally aired on June 6, 2022. QIAGEN CEO Thierry Bernard joins Yahoo Finance Live anchors Brian Cheung and Akiko Fujita to explain how his company is utilizing technology to track the spread of COVID through wastewater and also discusses how to track the monkeypox outbreak. Don't Miss: Valley of Hype: The Culture That Built Elizabeth Holmes WATCH HERE: • Elizabeth Holmes: 'Valley of Hype' [pre-sh... Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: • Video Subscribe to Yahoo Finance: https://yhoo.…
Qiagen CEO Thierry Bernard joins CNBC's "Squawk Alley" to break down how its new rapid coronavirus test works, and what it means for testing moving forward as the second wave of the virus starts to hit countries across the world. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis. From market futures to live pri…
CNBC's Meg Tirrell talks with Thierry Bernard, Qiagen CEO, about the medical company's coronavirus tests and the shipment of ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Thierry Bernard.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans